Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell Lymphoma

被引：0

作者：

Figura, N. ^{[1
]}

Sim, A. ^{[1
]}

Dahiya, S. ^{[2
,3
]}

Lutfi, F. ^{[2
,3
]}

Rapoport, A. ^{[2
,3
]}

Mohindra, P. ^{[4
]}

Dohm, A. ^{[1
]}

Chavez, J. ^{[5
]}

Shah, B. ^{[5
]}

Khimani, F. ^{[6
]}

Lazaryan, A. ^{[6
]}

Davila, M. ^{[6
]}

Bachmeier, C. ^{[6
]}

Nishihori, T. ^{[6
]}

Liu, H. ^{[6
]}

Kim, S. ^{[1
]}

Locke, F. ^{[6
]}

Jain, M. ^{[6
]}

Robinson, T. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA

[2] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA

[3] Univ Maryland, Sch Med, Greenebaum Comprehens Ctr, Baltimore, MD 21201 USA

[4] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Bone & Marrow Transplant & Cellular Immunoth, Tampa, FL USA

来源：

RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO-1075

引用

页码：S894 / S895

页数：2

共 50 条

[41] Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel
Romancik, Jason T.
Goyal, Subir
Gerson, James N.
Ballard, Hatcher J.
Sawalha, Yazeed
Bond, David A.
Rogalski, Michael Joseph
Greenwell, Irl Brian
van Besien, Koen
Yamshon, Samuel
Karmali, Reem
Nizamuddin, Imran
Torka, Pallawi
Chow, Victor A.
Shadman, Mazyar
Ghosh, Nilanjan
Moyo, Tamara K.
Fenske, Timothy S.
Rezazadeh, Alexandra
Grover, Natalie S.
Maddocks, Kami J.
Jacobson, Caron
Cohen, Jonathon B.
BLOOD, 2021, 138
[42] Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
Iacoboni, Gloria
Rejeski, Kai
Villacampa, Guillermo
van Doesum, Jaap A.
Chiappella, Annalisa
Bonifazi, Francesca
Lopez-Corral, Lucia
van Aalderen, Michiel
Kwon, Mi
Martinez-Cibrian, Nuria
Bramanti, Stefania
Luis Reguera-Ortega, Juan
Camacho-Arteaga, Lina
Schmidt, Christian
Marin-Niebla, Ana
Jose Kersten, Marie
Martin Garcia-Sancho, Alejandro
Zinzani, Pier Luigi
Corradini, Paolo
van Meerten, Tom
Subklewe, Marion
Barba, Pere
BLOOD ADVANCES, 2022, 6 (12) : 3606 - 3610
[43] Radiation therapy prior to CAR T-cell therapy in lymphoma: impact on patient outcomes
Figura, Nicholas B.
Sim, Austin J.
Jain, Michael D.
Chavez, Julio C.
Robinson, Timothy J.
EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (12) : 1023 - 1030
[44] CAR T-cell therapy in LMICs: approval of talicabtagene autoleucel in India
Paruzzo, Luca
Ruella, Marco
LANCET HAEMATOLOGY, 2025, 12 (04): : e236 - e238
[45] Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
Herbaux, Charles
Bret, Caroline
Bachy, Emmanuel
Bories, Pierre
Di Blasi, Roberta
Cuffel, Alexis
Gastinne, Thomas
Lamy, Thierry
Roussel, Mikael
Bouabdallah, Krimo
Beauvais, David
Cartron, Guillaume
Bay, Jacques-Olivier
Blaise, Didier
Rubio, Marie-Therese
Mohty, Mohamad
Le Bras, Fabien
Casasnovas, Olivier
Guy, Julien
Guidez, Stephanie
Llorente, Cristina Castilla
Hermine, Olivier
La Rochelle, Laurianne Drieu
Carras, Sylvain
Guffroy, Blandine
Caillat-Zucman, Sophie
Houot, Roch
Le Gouill, Steven
HAEMATOLOGICA, 2024, 109 (11) : 3745 - 3750
[46] Bridging Radiotherapy for Patients with Limited (<5 Disease Sites) Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Prior to CAR T-Cell Therapy
Saifi, Omran
Breen, William
Lester, Scott
Rule, William
Stish, Bradley
Rosenthal, Allison C.
Munoz, Javier
Lin, Yi
Johnston, Patrick B.
Ansell, Stephen M.
Paludo, Jonas
Khurana, Arushi
Villasboas, Jose. C.
Wang, Yucai
Iqbal, Madiha
Moustafa, Muhamad Alhaj
Murthy, Hemant S.
Ayala, Ernesto
Kharfan-Dabaja, Mohamed A.
Peterson, Jennifer
Hoppe, Bradford
BLOOD, 2023, 142
[47] CAR plus T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma
Harrison, Simon J.
Nguyen, Tamia
Rahman, Marzia
Er, Jeremy
Li, Jessica
Li, Katherine
Lendvai, Nikoletta
Schecter, Jordan M.
Banerjee, Arnob
Roccia, Tito
Foulk, Brad
Gu, Junchen
Zhao, Hao
Smirnov, Denis
Slaughter, Ana
Lonardi, Carolina
Lee, Erin
Marquez, Loreta
Jadidi, Shirin
Costa Filho, Octavio
Patel, Nitin
Geng, Dong
Haynes, Nicole M.
Kelly, Hannah
Lade, Stephen
Grimmond, Sean
Blombery, Piers
BLOOD, 2023, 142
[48] CAR T-Cell Therapy in Hodgkin Lymphoma
Ramos, Carlos A.
Quach, David H.
Rooney, Cliona M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S9 - S9
[49] CAR T-cell Therapy in Indolent Lymphoma
Jacobson, Caron A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S178 - S179
[50] Tecartus First CAR T-Cell Therapy FDA Approved for Patients with Mantle-Cell Lymphoma
Marks, Peter
AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (05): : 215 - 215

← 1 2 3 4 5 →